Ryaltris

Drug Hikma Pharmaceuticals USA
Total Payments
$255,921
Transactions
7,109
Doctors
3,863
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $115,962 3,047 2,066
2023 $128,431 3,467 2,304
2022 $11,529 595 525

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $131,839 7,039 51.5%
Consulting Fee $108,646 24 42.5%
Travel and Lodging $15,436 46 6.0%

Top Doctors Receiving Payments for Ryaltris — Page 155

Doctor Specialty Location Total Records
, M.D Allergy & Immunology Skyland, NC $11.89 1
, M. D Internal Medicine Brooklyn, NY $11.74 1
, PA-C Physician Assistant Columbia, SC $11.74 1
, DO Family Medicine Jacksonville, FL $11.71 1
, PA-C Medical Fayetteville, NC $11.69 1
, NP Family Fayetteville, NC $11.69 1
, MD Internal Medicine Chicago Heights, IL $11.68 1
, MD Internal Medicine Chicago Heights, IL $11.68 1
, M.D Otolaryngology Shreveport, LA $11.67 1
, M.D Otolaryngology Shreveport, LA $11.67 1
, MD Anesthesiology Carrollton, TX $11.64 1
, MSN, RN, NP, ANP-BC Nurse Practitioner Englewood, NJ $11.64 1
, MD Family Medicine Houston, TX $9.06 2

About Ryaltris

Ryaltris is a drug associated with $255,921 in payments to 3,863 healthcare providers, recorded across 7,109 transactions in the CMS Open Payments database. The primary manufacturer is Hikma Pharmaceuticals USA.

Payment data is available from 2022 to 2024. In 2024, $115,962 was paid across 3,047 transactions to 2,066 doctors.

The most common payment nature for Ryaltris is "Food and Beverage" ($131,839, 51.5% of total).